Keith Wharton
As Vice President and Medical Director at Ultivue, Keith is firmly focused on the future. His goal? “To bring single-cell omics and multiplex tissue labeling to diagnostic use, allowing pathologists to visualize in a histologic context the phenotype of every cell in a tissue biopsy.” He hopes that, in the future, advances in omics and in digital and computational pathology will allow the assembly of a tissue and organ atlas to support the unambiguous identification of specific pathogenic cell types in patient biopsies. His advice to newcomers? “Do not allow the decisions of a committee to determine your destiny.”
